Concepedia

Michael A. Sandoval

MA

Statistics

Publications

13

Citations

617

H-Index

12

Active since

2009

Affiliations

The University of Texas at Austin(Current)

Pediatrics and Genetics

Oregon State University

Michigan State University

Michael A. Sandoval is an author at The University of Texas at Austin specializing in nanomedicine, drug delivery, and nanoparticle drug delivery.

Publications per year

2009–2024

13

Publications

13

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

Brian R. Sloat, Michael A. Sandoval, Li Dong et al. · International Journal of Pharmaceutics · 2011 · 105 citations

Pharmacy, Oncology, Pharmacology +12

Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles

Brian R. Sloat, Michael A. Sandoval, Andrew M. Hau et al. · Journal of Controlled Release · 2009 · 81 citations · Full text

Life Sciences, Biochemistry, Immunology +16

Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles

Amit Kumar, Piyanuch Wonganan, Michael A. Sandoval et al. · Journal of Controlled Release · 2012 · 66 citations

Pharmacy, Biomedical Engineering, Biotechnology +16

EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity

Michael A. Sandoval, Brian R. Sloat, Dharmika S.P. Lansakara-P et al. · Journal of Controlled Release · 2011 · 64 citations

Pharmacy, Oncology, Pharmaceutics +14

Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1

Woon-Gye Chung, Michael A. Sandoval, Brian R. Sloat et al. · Journal of Controlled Release · 2011 · 60 citations

Life Sciences, Biochemistry, Molecular Biology +13

1–5 of 13